NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
17 hedge funds and large institutions have $4.24M invested in NKGen Biotech, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
25% less capital invested
Capital invested by funds: $5.66M → $4.24M (-$1.42M)
Holders
17
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$423K | |
| 2 | +$41.6K | |
| 3 | +$24K | |
| 4 |
BlackRock
New York
|
+$21.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.1K |
Top Sellers
| 1 | -$50.3K | |
| 2 | -$32K | |
| 3 | -$1.19K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$91 |